Abstract

Objective: This study aimed to explore the efficacy of interventional micro-circulation system (IMCS), combining the stromal cell-derived factor 1 (SDF-1)/type I collagen/chitosan composite membrane into TEB in treating with the model of goat tibial LSBD. Methods: The model of goat tibial LSBD was constructed by introducing the IMCS and SDF-1 guiding membrane. Perfusion treatment of CXCR4 + -BMSCs and BMP-2 was performed on the animal model, general conditions of the goats were observed, and changes in the goat's tibia was observed at different time points through imaging techniques. Using RNA extraction and reverse transcription, cDNA was acquired. Alkaline phosphatase (ALP), core binding factor-α1 (Cbfα1) and osteocalcin (OC) content, as well as the mRNA of transformation growth factor-β1 (TGF-β1) in fixed bone tissue samples of the goat, were detected by real-time quantitative PCR (RT-qPCR). Results: The model of goat tibial LSBD repaired by IMCS was successfully constructed. The standing, walking and running functions of the goat recovered well after two months; and imaging revealed that the callus was closely connected and most of the scaffold materials of TEB were absorbed. The detection of the ALP gene in bone tissue samples failed, and the amplified product was non-specific. Furthermore, the levels of Cbfα1, OC and mRNA of TGF-β1 were significantly higher than in normal bones (P < 0.05). Conclusion: The combination treatment of IMCS with slow controlled drug delivery systems and TEB functioned well in repairing goat tibial LSBD. This is a novel method for repairing bone defects.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call